About Jade Therapeutics
Jade Therapeutics is a company based in Salt Lake City (United States) founded in 2012 was acquired by EyeGate in March 2016. Jade Therapeutics operates in a competitive market with competitors including Kriya Therapeutics, Annexon, Aldeyra, Nicox and Gyroscope, among others.
- Headquarter Salt Lake City, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Jade Therapeutics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Jade Therapeutics
Investors in Jade Therapeutics
Jade Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include EyeGate and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked | |
|
Therapeutics and drug delivery systems for eye diseases are developed.
|
Locked | Locked | Locked |
Investor details for Jade Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Jade Therapeutics
Investment portfolio details for Jade Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Jade Therapeutics
Detailed financials for Jade Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Jade Therapeutics Comparisons
Peer comparison for Jade Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Jade Therapeutics
Jade Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kriya Therapeutics, Annexon, Aldeyra, Nicox and Gyroscope, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| Locked | Locked | Locked |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| Locked | Locked | Locked |
Drug candidates for immune-mediated diseases are developed by Aldeyra.
|
|
| Locked | Locked | Locked |
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
|
|
| Locked | Locked | Locked |
Mobile SDK developed for app engagement and monetization strategies.
|
|
| Locked | Locked | Locked |
Gene therapies for ocular and neurodegenerative diseases are developed.
|
Detailed competitors of Jade Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Jade Therapeutics
Complete news archive for Jade Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jade Therapeutics
Jade Therapeutics was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Jade Therapeutics is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Jade Therapeutics was founded in 2012 in Salt Lake City, United States, within the biotechnology sector. Locally administered polymer-based systems for treating ophthalmic conditions are developed, with transscleral iontophoresis employed to target drugs in anterior and posterior eye segments. An exclusive worldwide license to BioTime, Inc.s thiolated, cross-linked hyaluronic acid platform for ocular delivery was secured. The company was acquired by EyeGate Pharma in 2016.
Jade Therapeutics's top competitors include Annexon, Alimera Sciences and MeiraGTx.
Jade Therapeutics has 2 investors. Key investors include EyeGate, and National Science Foundation.